How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

363 results for

bell's palsy guideline

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Management of Thyroid Cancer

Management of Thyroid Cancer CLINICAL ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF THE SOCIETY FOR ENDOCRINOLOGY AND THE ENDOCRINE SOCIETY OF AUSTRALIA British Thyroid Association Guidelines for the Management of Thyroid CancerGuidelines for the management of thyroid cancer Third edition British Thyroid Association July 2014 Perros P, Colley S, Boelaert K, Evans C, Evans RM, Gerrard GE, Gilbert JA, Harrison B, Johnson SJ, Giles TE, Moss L, Lewington V , Newbold KL (...) , Taylor J, Thakker RV , Watkinson J, Williams GR cen_frontmatter.indd i cen_frontmatter.indd i 6/27/2014 3:52:19 PM 6/27/2014 3:52:19 PMii Acknowledgements Grateful thanks are expressed to the many reviewers of these guidelines. These included leading international experts in thyroid cancer, hospital specialists, and general practitioners. They devoted much time and care to considering the document and their recommendations and suggestions for improvements were most valuable. Special thanks to Dr

2014 British Thyroid Association

122. Perinatal care at the threshold of viability

Perinatal care at the threshold of viability Perinatal care at the threshold of viability Queensland Clinical Guideline: Perinatal care at the threshold of viability Refer to online version, destroy printed copies after use Page 2 of 35 Document title: Perinatal care at the threshold of viability Publication date: September 2014 Document number: MN14.32-V1-R19 Document supplement: The document supplement is integral to and should be read in conjunction with this guideline. Amendments Full (...) version history is supplied in the document supplement. Amendment date: New document Replaces document: New document Author: Queensland Clinical Guidelines Audience: Health professionals in Queensland public and private maternity services Review date: September 2019 Endorsed by: Queensland Clinical Guidelines Steering Committee Statewide Maternity and Neonatal Clinical Network Contact: Email: Guidelines@health.qld.gov.au URL: www.health.qld.gov.au/qcg Disclaimer These guidelines have been prepared

2014 Clinical Practice Guidelines Portal

123. Osteoarthritis of the Knee

Osteoarthritis of the Knee TREATMENT OF OSTEOARTHRITIS OF THE KNEE EVIDENCE-BASED GUIDELINE 2 ND EDITION Adopted by the American Academy of Orthopaedic Surgeons Board of Directors May 18, 2013 i Disclaimer This clinical practice guideline was developed by an AAOS work group comprised of volunteer physicians and interdisciplinary clinicians as well as staff researchers with expertise in systematic reviews and statistical methods used to evaluate empirical evidence. It is an educational tool (...) that integrates the current scientific literature and the proficiency and sound judgment that physicians typically acquire in clinical practice. The recommendations that make up this guideline are not intended to be absolute as patients vary in how they experience symptoms and respond to treatment interventions. There may be variability between patients in practice and those who participate in clinical trials. Medical care should always be based on a physician’s expertise that is individually tailored

2013 American Academy of Orthopaedic Surgeons

124. Diagnosis and Management of Prosthetic Joint Infection (Full text)

Diagnosis and Management of Prosthetic Joint Infection We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa | Clinical Infectious Diseases | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close (...) search filter search input Article Navigation Close mobile search navigation Article navigation 1 January 2013 Article Contents Article Navigation Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America Douglas R. Osmon 1Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota Correspondence: Douglas R. Osmon, Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic College

2013 Infectious Diseases Society of America PubMed abstract

125. An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare professionals from the American Heart Association/American Stroke Association (Full text)

and contrasting studies in which different definitions are used for inclusion of cases or ascertainment of outcomes is difficult. The advent of thrombolysis and other hyperacute treatments has added to the need to redefine stroke and TIA, because many current guidelines differentiate treatment strategies for these 2 entities. Treatment of patients with CNS ischemia should be directed to the cause and not governed only by whether infarction has developed. However, the location and extent of infarction is one

2013 Congress of Neurological Surgeons PubMed abstract

126. Occipital Condyle Fractures (Full text)

should be considered for bilateral OCF. Halo vest immobilization or occipitocervical stabilization and fusion are recommended for injuries with associated atlanto occipital ligamentous injury or evidence of instability. RATIONALE Acute traumatic OCF was first described by Bell in 1817. More frequent observations of this injury have been reported during the past 2 decades. Improvements in CT imaging technology and the use of CT imaging of head-injury patients that includes visualization (...) treatment strategies for OCF including no treatment, traction, external immobilization, and surgical decompression with internal fixation and fusion. The guidelines author group of the Section on Disorders of the Spine and Peripheral Nerves of the American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) produced a medical evidence-based guideline on this topic in 2002. The purpose of the current review is to update the medical evidence on the diagnosis

2013 Congress of Neurological Surgeons PubMed abstract

127. An updated definition of stroke for the 21st century (Full text)

is difficult. The advent of thrombolysis and other hyperacute treatments has added to the need to redefine stroke and TIA, because many current guidelines differentiate treatment strategies for these 2 entities. Treatment of patients with CNS ischemia should be directed to the cause and not governed only by whether infarction has developed. However, the location and extent of infarction is one variable to consider when choosing treatment. Time and Imaging Early definitions of stroke and TIA focused

2013 American Academy of Neurology PubMed abstract

128. Tropical Travel Trouble 008 Total TB Extravaganza

protocols in the developed world). Q9. How do you treat drug resistant TB? Answer and interpretation Golden rule: due to its rarity in some countries, including the UK, each patient should be discussed with a specialist and with a MDRTB centre or forum. Do not add one drug to a failing regimen. Always add two. This is a general rule but will depend on the information you have to hand. Definitions used in the guidelines: Monoresistance: resistance to one first-line drug, usually isoniazid. – Multi drug (...) agents and are susceptible to these agents selected plus fluroquinolones, a shorter MDR-TB regimen of 9-12 months may be used instead (low certainty of evidence). TB multidrug resistance treatment guideline Q10a. TB can occur at other sites (it’s always on a medical student differential and essentially if you think of an organ … it can have TB), can you match the photos below to some of the TB presentations? Image 1 Image 2 Image 3 Answer and interpretation 12% of TB cases are extra pulmonary. More

2018 Life in the Fast Lane Blog

129. Management of suspected viral encephalitis in children (Full text)

Management of suspected viral encephalitis in children Management of suspected viral encephalitis in children – Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group National Guidelines - Journal of Infection Email/Username: Password: Remember me Search Terms Search within Search Access provided by Volume 64, Issue 5, Pages 449–477 Management of suspected viral encephalitis in children – Association of British Neurologists and British Paediatric (...) Allergy, Immunology and Infection Group National Guidelines x R. Kneen Affiliations Alder Hey Children's NHS Foundation Trust, Eaton Road, West Derby, Liverpool L12 2AP, UK Institute of Infection and Global Health, University of Liverpool, 8th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK Correspondence Corresponding author. Tel.: +44 151 228 4811; fax: +44 151 228 032. a , b , r , ∗ , x R. Kneen Affiliations Alder Hey Children's NHS Foundation Trust, Eaton Road, West Derby, Liverpool

2012 British Infection Association PubMed abstract

130. Management of suspected viral encephalitis in adults

Management of suspected viral encephalitis in adults Management of suspected viral encephalitis in adults – Association of British Neurologists and British Infection Association National Guidelines - Journal of Infection Go search , P347-373, April 01, 2012 Powered By Mendeley Share on Management of suspected viral encephalitis in adults – Association of British Neurologists and British Infection Association National Guidelines Author Footnotes u TS and BDM are joint first authors. T. Solomon (...) Footnotes p Tel.: +44 151 706 2000. Affiliations Tropical and Infectious Disease Unit, Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, UK On behalf of the National Encephalitis Guidelines Development and Stakeholder Groups Author Footnotes l Tel.: +44 151 529 5460; fax: +44 151 529 5465. m Tel.: +44 292 074 8701x2834. n Tel.: +44 20 8383 2546. o Tel.: +44 20 8746 8000. p Tel.: +44 151 706 2000. q Tel.: +44 161 998 7070. r Tel.: +44 1653 692 583; fax: +44 1653 604 369. s Tel.: +44

2012 British Infection Association

131. Lactoferrin Infant Feeding Trial

: Randomization to 36 weeks corrected gestation or to transfer/discharge if earlier. ] Hospital mortality or major morbidity at 36 weeks corrected gestation defined as: Brain injury on ultrasound Chronic lung disease Necrotizing enterocolitis (Bell stage II or higher ) Late onset sepsis (≥ 72 hours of life, culture proven), or Retinopathy of prematurity treated according to local guidelines before discharge from hospital. Secondary Outcome Measures : Incidence of all-cause in-hospital mortality [ Time Frame (...) gestation ] Incidence of death by 24 months corrected age or the presence of major neurodevelopmental outcomes at 24 months corrected age, as defined: (i) visual (cannot fixate/ legally blind, or corrected acuity <6/60 in both eyes), or hearing impairment (requiring a hearing aid or cochlear implants); (ii) cerebral palsy with an inability to walk unassisted; (iii) major developmental delay involving cognition or speech (composite score < 85 for cognition or language on assessment) Eligibility Criteria

2017 Clinical Trials

132. APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies

evaluation due to tumor involvement of the central nervous system (CNS). History of Bell's palsy Active rheumatoid arthritis (RA), active inflammatory bowel disease, chronic infections, or any other disease or condition associated with chronic inflammation Active infection requiring systemic antibiotic/ antifungal medication, Known or suspected Wilson's Disease. Prior treatment with IAP inhibitors History of hypersensitivity to paclitaxel, or any therapeutic antibody Has an active autoimmune disease (...) : Maximum Tolerated Dose (MTD) [ Time Frame: 18-24 months ] Patients with APG-1387 treatment related adverse events (AE), serious adverse events (SAE) will be assessed according NCI CTCAE Version 4.0 Secondary Outcome Measures : Anti-tumor effects of APG-1387 as a single agent [ Time Frame: 18-24 months ] Response will be evaluated every 2 cycles (8 weeks), according to the revised RECIST Guideline, Version 1.1 or the Revised Response Criteria for Malignant Lymphoma (Cheson, 2007). Pharmacokinetic

2017 Clinical Trials

133. Cobimetinib and Atezolizumab in Advanced Rare Tumors

but not limited to systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis associated with antiphospholipid syndrome, Wegener's granulomatosis, Sjögren's syndrome, Bell's palsy, Guillain-Barré syndrome, multiple sclerosis, autoimmune thyroid disease, vasculitis, or glomerulonephritis a. Patients with a history of autoimmune hypothyroidism on a stable dose of thyroid replacement hormone may be eligible. b. Patients with controlled Type 1 diabetes mellitus on a stable (...) nature of this study and must be willing to give written informed consent in accordance with institutional and federal guidelines. Patients must be able to comply with the requirements and assessments of the study protocol Fertile men and women must use an effective method of contraception during treatment and for at least 6 months after completion of treatment as directed by their physician. Effective methods of contraception are defined as those that result in a low failure rate (i.e., less than 1

2017 Clinical Trials

134. Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma

, corticosteroids or immunosuppressive drugs); replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) is not considered a form of systemic treatment; autoimmune diseases include, but are not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis associated with antiphospholipid syndrome, Wegener's granulomatosis, Sjogren's syndrome, Bell's palsy, Guillain-Barre (...) for translational medicine studies Patient must be offered the opportunity to participate in tissue and blood banking for future studies Patient must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines As a part of the Oncology Patient Enrollment Network (OPEN) registration process, the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional

2017 Clinical Trials

135. Paclitaxel, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Patients With Metastatic Breast Cancer

associated with antiphospholipid syndrome, Wegener's granulomatosis, Sjogren's syndrome, Bell's palsy, Guillain-Barre syndrome, multiple sclerosis, autoimmune thyroid disease, vasculitis, or glomerulonephritis Patients with a history of autoimmune hypothyroidism on a stable dose of thyroid replacement hormone may be eligible Patients with controlled type 1 diabetes mellitus on a stable insulin regimen may be eligible Patients with eczema, psoriasis, lichen simplex chronicus of vitiligo with dermatologic (...) may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 18 Years and older (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: The patient must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines Patient must have an Eastern Cooperative Oncology Group

2017 Clinical Trials

136. Eye movement assessment protocol

, allowing for their detailed 144 analysis. 145 The aim of this recommended procedure is to clarify the methodology and 146 interpretation of findings. This should allow a standardised method to be used in 147 most cases. Alternative methodologies may be required in certain cases, but 148 there must be robust evidence to justify doing so. 149 3.3. Scope 150 This protocol provides guidelines for testing using ENG or VNG with 151 commercially available systems. The test battery is used for the assessment (...) with eyes closed 215 Although not recommended, some tests can be carried out with eyes closed (e.g. 216 search for spontaneous or gaze-evoked nystagmus without visual fixation, 217 rotational and caloric tests) but one should be aware of artefacts, such as non- 218 pathological up-beating spontaneous nystagmus (SN) and Bell’s phenomenon. 219 4.4. Visual impairments and ophthalmic disorders 220 Blindness or severe visual impairment may affect the results. If a patient with 221 significant refractive

2014 British Society of Audiology

137. Management of Thyroid Cancer

Management of Thyroid Cancer CLINICAL ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF THE SOCIETY FOR ENDOCRINOLOGY AND THE ENDOCRINE SOCIETY OF AUSTRALIA British Thyroid Association Guidelines for the Management of Thyroid CancerGuidelines for the management of thyroid cancer Third edition British Thyroid Association July 2014 Perros P, Colley S, Boelaert K, Evans C, Evans RM, Gerrard GE, Gilbert JA, Harrison B, Johnson SJ, Giles TE, Moss L, Lewington V , Newbold KL (...) , Taylor J, Thakker RV , Watkinson J, Williams GR cen_frontmatter.indd i cen_frontmatter.indd i 6/27/2014 3:52:19 PM 6/27/2014 3:52:19 PMii Acknowledgements Grateful thanks are expressed to the many reviewers of these guidelines. These included leading international experts in thyroid cancer, hospital specialists, and general practitioners. They devoted much time and care to considering the document and their recommendations and suggestions for improvements were most valuable. Special thanks to Dr

2014 British Association of Endocrine and Thyroid Surgeons

138. Unusual Cancers of Childhood Treatment (PDQ®): Health Professional Version

guidelines or recommendations for making health care decisions. This summary is reviewed regularly and updated as necessary by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of the National Cancer Institute (NCI). The summary reflects an independent review of the literature and does not represent a policy statement of NCI or the National Institutes of Health (NIH). General Information About Unusual Cancers of Childhood Introduction Cancer in children and adolescents is rare (...) specialists, pediatric nurse specialists, social workers, and others to ensure that children receive treatment, supportive care, and rehabilitation that will achieve optimal survival and quality of life. (Refer to the PDQ summaries for specific information about supportive care for children and adolescents with cancer.) Guidelines for pediatric cancer centers and their role in the treatment of pediatric patients with cancer have been outlined by the American Academy of Pediatrics.[ ] At these pediatric

2016 PDQ - NCI's Comprehensive Cancer Database

139. Family Practice Notebook Updates 2016

Do not treat with a single drug regimen until is excluded by history, In suspected , mask patient in negative ariflow room and induce for AFB x3 samples has not changed substantially in 10 years, but multi-drug resistance guidelines are lacking (er, procedure, fen) Quick central access without Seldinger technique (id, std) Syphilis has increased 3-4 fold in the U.S. since 2000 (now at 20,000 cases per year) is typically treated with G (or , ) for primary and secondry Avoid in due to resistance (...) Gradually developed wbc to 3.5k, hgb from 13 to 12 to 11 over 1 week of serial visits for s demonstrated RBC inclusion bodies consistent with Updated to include In failed airway, may temporize in infants and young children for 20-25 min Covers reversal of specific s (e.g. DIC, TTP, disease, renal disease, s) or (id, immunize, ) Very low efficacy in U.S. as of 2016 (as low as 3%) and will not be used in U.S. per ACIP guidelines (endo, pharm, dm) For all its mediocre activity on lowering and adverse

2018 FP Notebook

140. Late Effects of Treatment for Childhood Cancer (PDQ®): Health Professional Version

patients. It does not provide formal guidelines or recommendations for making health care decisions. This summary is reviewed regularly and updated as necessary by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of the National Cancer Institute (NCI). The summary reflects an independent review of the literature and does not represent a policy statement of NCI or the National Institutes of Health (NIH). General Information About Late Effects of Treatment for Childhood (...) be used by survivors to organize a personal treatment summary (refer to the COG ). COG Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers To facilitate survivor and provider access to succinct information to guide risk-based care, COG investigators have organized a compendium of exposure- and risk-based health surveillance recommendations, with the goal of standardizing the care of childhood cancer survivors.[ ] The compendium of resources includes

2016 PDQ - NCI's Comprehensive Cancer Database

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>